Friday, July 22, 2016

Acid Reflux Drugs for Cancer?

The latest news from Doctor's Choice!
View this email in your browser

Acid Reflux Drugs for Cancer? Doc

Products like Zantac and Pepcid AC are currently being studied for their potential in cancer treatment.

Scientists at Dalhousie University are 
investigating whether ranitidine and famotidine (known as Zantac and Pepcid AC) could help the body's immune system when fighting cancer. The scientists theorize that these ingredients could change the immune system so that it can slow the development of tumors.

The problem with this approach is that chemotherapy creates digestive problems, as it
damages healthy cells lining of the digestive system. Adding symptom-treating drugs on top of symptom-creating drugs is not doing an already weakened immune system any favours. In fact, as noted before, heartburn medications can block nutrient absorption, leading to a greater risk of bone fracture.

Hippocrates famously said, "All disease begins in the gut." Multiple studies have shown how gut health affects mental and physical health. A few examples are listed below:
The best way to heal the gut is by bringing it back into a balanced state of health and the first place healing is needed is within the gastrointestinal tract. The best method for restoring gastrointestinal health is by incorporating pharmaceutical quality therapeutic nutrients such as probiotics and digestive enzymes. Our Laktokhan Probiotic and Full Spectrum Digestive Enzyme are great tools in order to achieve optimal health.

With over 10 years of experience, Bond Consulting is a leader in the SR&ED industry. The SR&ED program is designed to support innovative companies with cash reimbursements from the Canadian Government due to their private R&D efforts. (

Copyright © *|2016|* *|Doctor's Choice TM|*, All rights reserved.

Our Contact Info is:
Address: P.O. Box 1696 Station Main, Cochrane, AB T4C 1B6
Tel: 866-226-1722
Fax: 866-226-1822

unsubscribe from this list    update subscription preferences 

No comments:

Post a Comment